Holly A. Swartz, MD, is an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She received her medical degree from Albert Einstein College of Medicine and completed her residency in psychiatry at New York Hospital/Cornell University School of Medicine.

 

Dr. Swartz's research focuses on improving outcomes for individuals suffering from mood disorders. She is currently conducting a randomized controlled trial, funded by the National Institute of Mental Health (NIMH), evaluating the role of interpersonal and social rhythm therapy and pharmacotherapy in the management of bipolar II depression. Concerned about the intergenerational transmission of mood disorders, Dr. Swartz is also conducting an NIMH-funded trial evaluating the impact of treating maternal depression on offspring with psychiatric illness. The author or coauthor of more than 60 peer-reviewed articles, chapters, and invited articles, she has presented her work at numerous local, national, and international workshops, conferences, and scientific meetings.

 

Dr. Swartz has received grant support from NIMH, Staunton Farm Foundation, Bristol-Myers Squibb, and the National Alliance for Research on Schizophrenia and Depression. She is the recipient of numerous awards, including a Reader's Digest Research Fellowship from Cornell University Medical College, a Junior Faculty Scholar Award from the University of Pittsburgh Department of Psychiatry, a New Clinical Drug Evaluation Unit New Investigator Award from NIMH, and the Gerald L. Klerman Young Investigator Award from the Depression and Bipolar Support Alliance.

Dr. Allen attended Florida State University, received his medical degree from the Medical University of South Carolina and trained in psychiatry at the Institute of Living where he served as Chief Resident.  He went on to serve on the faculty of Cornell and later New York University School of Medicine.  While at NYU, he developed the model Comprehensive Psychiatric Emergency Program at Bellevue Hospital, mentioned in New York Magazine's "Best Hospitals in New York." 

Currently he is medical director of the University of Colorado Hospital Psychiatry Department and director of research at the University of Colorado Depression Center, part of the National Network of Depression Centers.  He was a principal investigator in the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder and other studies in schizophrenia and bipolar disorder.  He developed and validated the Clinical Global Impression for Schizoaffective Disorder, has served as a research trainer internationally and received a NARSAD Independent Investigator award for the study of agitation.  He is now helping to launch ED-SAFE, the NIH Emergency Department Safety and Follow-up Evaluation suicide screening and prevention study.      

 

He has served as president of the American Association for Emergency Psychiatry and vice president of the International Association for Emergency Psychiatry, chair of the American Psychiatric Association Task Force on Psychiatric Emergency Services, panelist for the Expert Consensus Guideline for Bipolar Disorder and the Colorado Clinical Guidelines Collaborative Depression Program, lead expert for the Expert Consensus Guideline for the Management of Behavioral Emergencies, member of the American College of Emergency Physicians clinical policy committee and reviewer for the Cochrane Collaborative.  He is the author or editor of three books and associate editor of General Hospital Psychiatry.  He is board certified in psychiatry with added qualifications in addictions and is a certified QPR suicide prevention gatekeeper instructor.  He is a professor of psychiatry at the University of Colorado Denver and a Distinguished Fellow of the APA.

 

Dr. McIntyre's multiple research endeavors primarily aim to characterize the association between mood disorders and medical comorbidity by elucidating metabolic adverse events associated with the use of psychotropic medications and by examining both the impact of medical comorbidity on the course of mood disorders and the effect of glucose homeostasis on neurocognition. He is a contributor to the Canadian Psychiatric Association (CPA) guidelines for the treatment of depressive disorders and the Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of bipolar disorder. Dr. McIntyre has published extensively in leading peer-reviewed journals and textbooks. He is also a reviewer for many journals, including The American Journal of Psychiatry, Biological Psychiatry, The Journal of Clinical Psychiatry, and The New England Journal of Medicine.

 

A highly sought-after speaker at both national and international meetings, Dr. McIntyre is extensively involved in medical education. He has received teaching awards from the Department of Psychiatry at the University of Toronto as well as the joint CPA/Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.

 

Dr. McIntyre obtained his medical degree from Dalhousie University in Halifax, Nova Scotia. He completed his residency in psychiatry and held a fellowship in psychiatric pharmacology at the University of Toronto.